Anti-dementia regimen
First Claim
Patent Images
1. A formulation comprising the following supplemental components:
- (a) idebenone at about 180 mg;
(b) rhodiola at about 400 mg;
(c) gingko biloba at about 160 mg;
(d) thionine at about 400 mg;
(e) huperzine a at about 2 mg;
(f) coenzyme Q10 at about 400 mg;
(g) alpha lipoic acid at about 600 mg;
(h) melatonin at about 3 mg;
(i) omega 3 fatty acid at about 6000 mg;
(j) zinc carnosine at about 500 mg;
(k) magnesium at about 1000 mg;
(l) vitamin E (mixed tocotrienols gamma and delta) at about 1000 mg;
(m) n-acetyl cysteine at about 1200 mg;
(n) dehydroepiandrosterone (dhea) at about 100 mg;
(o) pregnenolone at about 60 mg;
(p) niacin at about 1000 mg;
(q) phosphotidylserine docasahexanenoic acid at about 300 mg;
(r) vitamin B12 at about 2000 mg;
(s) vitamin B6 at about 200 mg;
(t) iron at about 18 mg;
(u) vinpocetine at about 40 mg;
(v) grapeseed extract at about 300 mg;
(w) blueberry extract at about 300 mg;
(x) acetyl l-carnitine arginate 900 mg;
(y) ashwagandha extract at about 250 mg;
(z) uridine 5 monophosphate at about 100 mg;
(aa) French maritime pine bark extract at about 250 mg;
(bb) l-alpha-glycerylphosphorylcholine at about 1500 mg;
(cc) curcumin at about 8 gms;
(dd) coconut oil at about 1000 mg;
(ee) astaxanthin at about 20 mg;
(ff) chromium picolinate at about 1200 mg;
(gg) carnosine at about 3000 mg;
(hh) n-acetyl-tyrosine at about 1500 mg;
(ii) phenylalanine at about 1500 mg;
(jj) quercetin at about 150 mg;
(kk) inositol hexanicotinate at about 1000 mg;
(ll) dimethylethanolamine (DMAE) at about 100 mg;
(mm) s-adenosylmethionine at about 400 mg;
(nn) riboflavin B2 at about 200 mg;
(oo) thiamine B1 at about 50 mg;
(pp) selenium at about 200 mg;
(qq) colostrum at about 4000 mg;
(rr) lecithin (26% phosphaticylcholine) at about 300 mg;
(ss) vitamin D2 at about 8000 IU.
0 Assignments
0 Petitions
Accused Products
Abstract
A novel dietary supplement is featured which can benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, dementia/Alzheimer'"'"'s disease, high blood pressure, high cholesterol, coronary artery disease, stroke and mental cognition.
-
Citations
1 Claim
-
1. A formulation comprising the following supplemental components:
-
(a) idebenone at about 180 mg; (b) rhodiola at about 400 mg; (c) gingko biloba at about 160 mg; (d) thionine at about 400 mg; (e) huperzine a at about 2 mg; (f) coenzyme Q10 at about 400 mg; (g) alpha lipoic acid at about 600 mg; (h) melatonin at about 3 mg; (i) omega 3 fatty acid at about 6000 mg; (j) zinc carnosine at about 500 mg; (k) magnesium at about 1000 mg; (l) vitamin E (mixed tocotrienols gamma and delta) at about 1000 mg; (m) n-acetyl cysteine at about 1200 mg; (n) dehydroepiandrosterone (dhea) at about 100 mg; (o) pregnenolone at about 60 mg; (p) niacin at about 1000 mg; (q) phosphotidylserine docasahexanenoic acid at about 300 mg; (r) vitamin B12 at about 2000 mg; (s) vitamin B6 at about 200 mg; (t) iron at about 18 mg; (u) vinpocetine at about 40 mg; (v) grapeseed extract at about 300 mg; (w) blueberry extract at about 300 mg; (x) acetyl l-carnitine arginate 900 mg; (y) ashwagandha extract at about 250 mg; (z) uridine 5 monophosphate at about 100 mg; (aa) French maritime pine bark extract at about 250 mg; (bb) l-alpha-glycerylphosphorylcholine at about 1500 mg; (cc) curcumin at about 8 gms; (dd) coconut oil at about 1000 mg; (ee) astaxanthin at about 20 mg; (ff) chromium picolinate at about 1200 mg; (gg) carnosine at about 3000 mg; (hh) n-acetyl-tyrosine at about 1500 mg; (ii) phenylalanine at about 1500 mg; (jj) quercetin at about 150 mg; (kk) inositol hexanicotinate at about 1000 mg; (ll) dimethylethanolamine (DMAE) at about 100 mg; (mm) s-adenosylmethionine at about 400 mg; (nn) riboflavin B2 at about 200 mg; (oo) thiamine B1 at about 50 mg; (pp) selenium at about 200 mg; (qq) colostrum at about 4000 mg; (rr) lecithin (26% phosphaticylcholine) at about 300 mg; (ss) vitamin D2 at about 8000 IU.
-
Specification